Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1,610.00
-181.00 (-10.11%)
May 15, 2026, 1:47 PM IDT

TLV:TKUN Income Statement

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
9.134.9544.2349.337.03
Revenue Growth (YoY)
-73.96%-20.97%-10.28%33.13%70.97%
Cost of Revenue
7.3529.5332.731.1929.38
Gross Profit
1.755.4311.5318.117.65
Selling, General & Admin
10.4712.6222.8223.9527.66
Research & Development
-0.833.895.167.2
Other Operating Expenses
-1.62-0.12-0.81-0.330.85
Operating Expenses
9.7219.9839.1944.4550.7
Operating Income
-7.97-14.55-27.66-26.34-43.05
Interest Expense
-1.12-1.88-2.3-1.77-1.28
Interest & Investment Income
0.04-0.130.090.01
Earnings From Equity Investments
---0.38--
EBT Excluding Unusual Items
-9.05-16.44-30.21-28.02-44.32
Impairment of Goodwill
-11.27-22.34-59.63-17.57-
Gain (Loss) on Sale of Investments
--4.73-0.431.93-
Gain (Loss) on Sale of Assets
-0.84--0.17--
Asset Writedown
----15.27-
Other Unusual Items
5.343.4-3.569.7910.29
Pretax Income
-15.82-40.1-93.99-49.14-34.03
Income Tax Expense
--0.030.01-
Earnings From Continuing Operations
-15.82-40.1-94.02-49.15-34.03
Minority Interest in Earnings
-0.0305.130.911.38
Net Income
-15.85-40.1-88.89-48.24-32.65
Net Income to Common
-15.85-40.1-88.89-48.24-32.65
Shares Outstanding (Basic)
11100
Shares Outstanding (Diluted)
11100
Shares Change (YoY)
1.48%32.86%29.54%15.79%23.01%
EPS (Basic)
-18.66-47.90-141.05-99.16-77.72
EPS (Diluted)
-18.66-47.90-141.05-99.16-77.72
Free Cash Flow
2.01-3.78-4.12-23.2-33.49
Free Cash Flow Per Share
2.37-4.52-6.54-47.70-79.70
Gross Margin
19.25%15.52%26.06%36.73%20.66%
Operating Margin
-87.53%-41.63%-62.53%-53.44%-116.25%
Profit Margin
-174.17%-114.73%-200.97%-97.85%-88.17%
Free Cash Flow Margin
22.08%-10.82%-9.31%-47.07%-90.43%
EBITDA
3.9614.2229.089.2-25.89
EBITDA Margin
43.52%40.69%65.74%18.66%-69.92%
D&A For EBITDA
11.9328.7756.7335.5417.15
EBIT
-7.97-14.55-27.66-26.34-43.05
EBIT Margin
-87.53%-41.63%-62.53%-53.44%-116.25%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.